WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. WebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... SEC Filings. GlobeNewswire ...
CYTK Stock Forecast, Price & News (Cytokinetics) - MarketBeat
WebApr 9, 2024 · Cytokinetics Trading Up 0.7 %. Cytokinetics stock opened at $36.42 on Friday. The business’s 50 day simple moving average is $39.79 and its 200 day simple moving average is $42.22. WebJan 8, 2024 · According to the 10-Q SEC Filing, Cytokinetics had cash, cash equivalents and investments of $668.9 million as of September 30, 2024. A big reason for the cash on hand was because of an offering ... running 12 months
SEC Filing Cytokinetics, Inc.
WebMar 13, 2024 · Thornburg Investment Management Inc. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 74,198 shares of the biop WebFeb 24, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … scavenger hunt ideas birthday